Reboot Rx Inc
Reboot Rx Inc's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $160,172 for Laura Kleiman, President Ceo And Director (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $164,387. It is higher than the D + F figure for 66 of 138 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.71–1.4× revenue (approximately 48%; median $170,376). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Reboot Rx Inc, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.71–1.4× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| National Pert Consortium Inc | NH | $2,717,033 | $357,519 |
| Hope For Depression Research Foundation | NY | $2,671,993 | $293,242 |
| For Pete's Sake Cancer Respite | PA | $2,669,907 | $162,312 |
| Setting Scoliosis Straight Foundation | CA | $2,745,752 | $206,071 |
| Richmond Medical Center Foundation Inc | NY | $2,748,386 | $242,843 |
| Orthocarolina Research Institute Inc | NC | $2,643,097 | $208,953 |
| Sarc | MI | $2,780,009 | $367,269 |
| Cure Sanfilippo Foundation | SC | $2,781,149 | $186,697 |
View the organization record and available filings on ProPublica